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AbstrAct
Objectives To evaluate the prevalence of seroconversion 
to Toxoplasma gondii in dogs with uveitis and dogs without 
uveitis.
Methods In total, 135 dogs were evaluated: 51 dogs were 
diagnosed with uveitis, and 84 dogs were without uveitis. 
Latex agglutination tests were performed on all sera, and 
the results were evaluated.
Results Overall, 7.8 and 6.0 per cent of sera were 
positive for the presence of anti-T gondii antibodies 
(dilution ≥1:64) in the groups with uveitis and non-uveitis 
dogs, respectively. The frequency distribution of variables 
(positive and negative results in the uveitis and the non-
uveitis group of dogs) was tested with Fisher's exact test. 
There was no statistically significant difference between 
groups (P=0.73).
Clinical significance These findings suggest that 
evidence of exposure to T gondii was not significantly 
different between uveitis and non-uveitis groups of dogs 
and that the possible association between exposure to T 
gondii and canine uveitis requires further investigation. 
This study is the first to report the seroprevalence of anti-T 
gondii antibodies in dogs in the UK population and the first 
to report the seroprevalence of anti-T gondii antibodies in 
dogs with uveitis.
IntROduCtIOn
Toxoplasma gondii is an obligate intracellular 
protozoan that is remarkable in its ability to 
infect any nucleated cell in all warm-blooded 
animals.1 Animals may become infected by 
one of three means: ingestion of sporulated 
oocysts (sporozoites) from an environment 
contaminated by cat faeces; ingestion of 
tissue cysts or bradyzoites from carnivorism 
of animals that have been infected with T 
gondii; or congenital transmission of the 
organism.2 The pathogenesis of toxoplas-
mosis has historically been considered to be 
the result of a direct cytopathic effect, that 
is, cellular necrosis by intracellular growth 
of the organism T gondii, as the organism 
produces no toxins that damage cells.2 The 
definitive hosts for T gondii are domestic cats 
and other Felidae where oocysts may be shed 
in faeces.2 Intermediate hosts are probably all 
warm-blooded animals including most live-
stock, and humans.2 In these intermediate 
hosts, the organism replicates in the tissues, 
but a gut life cycle does not occur, and no 
faecal oocysts are shed.2 
A study by Lappin et al showed that anterior 
uveitis developed in serologically negative cats 
84 days after oral inoculation with T gondii.3 
In the same study, four cats presented with 
retinal scars at 15 days after inoculation, with 
similar observations at 80 days after inocu-
lation.3 In dogs, keratoconjunctivitis, epis-
cleritis, scleritis, optic neuritis, choroiditis, 
retinitis, ciliary epithelial hyperplasia, ante-
rior uveitis, iridocyclitis, posterior uveitis and 
panuveitis have all been reported in associa-
tion with toxoplasmosis.2 4–6
In humans, it is believed that the majority 
of horizontal transmissions are caused by 
ingestion of one of the two persistent stages 
of T gondii, that is, tissue cysts in infected 
meat or offal (viscera) and oocysts in food or 
water contaminated with feline faeces.7 Sero-
prevalence in humans is affected by many 
factors.8 Climatic factors play a significant 
role in oocyst survival in the environment and 
hence alter infection rates in meat-producing 
animals.8 Lifestyle factors explain a large part 
of the variation in human seroprevalence, 
including dietary habits (methods of cooking 
meat, hand washing, kinds of meat and vege-
tables consumed, and so on), and economic, 
social or cultural habits including water 
quality and sanitation coverage.8 In humans 
with ocular toxoplasmosis, an active lesion 
presents as grey-white foci of retinal necrosis 
with adjacent choroiditis, vasculitis, haemor-
rhage and vitritis.9 Cicatrisation occurs from 
the periphery towards the centre, with vari-
able pigmentary changes.9 Anterior uveitis 
is another common finding, with mutton-fat 
keratic precipitates, cells and aqueous flare, 
and posterior synechiae.9
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The seroprevalence of anti-T gondii antibodies in dogs 
varies considerably between studies, ranging from 1.8 to 
96.3 per cent.10 11 Currently there are no reports of the 
seroprevalence of anti-T gondii antibodies in dogs in the 
UK.
The paucity of clinical reports of ocular toxoplasmosis 
in dogs suggests that it is not a common cause of clini-
cally important ocular inflammatory disease.2 Toxoplasma 
serology is often a routine part of clinical investigation 
for canine uveitis, but in the authors’ experience T gondii 
has rarely been proved to be the cause of clinical disease. 
This study was designed to investigate T gondii seropreva-
lence and its association with canine uveitis.
MateRIals and MethOds
animals and inclusion criteria
The study was approved by the Recognised Veterinary 
Practice (RVP) Subcommittee of The Royal College of 
Veterinary Surgeons and performed at South Devon 
Referrals, Abbotskerswell, UK. In accordance with the R 
VP guidance, only waste blood samples were included for 
the purpose of the study.
Latex agglutination tests (LAT), Toxoreagent RST701 
(Eiken Chemical, Tokyo, Japan [Mast Diagnostics, 
Bootle, UK]) results in dogs that presented to the referral 
centre, were collected both retrospectively (June 2005 
to December 2014) and prospectively (January 2015 to 
December 2015).
All LATs were run by the same referral veterinary labo-
ratory, Axiom Veterinary Laboratories (the laboratory), 
for the presence of anti-T gondii antibodies. Dogs were 
divided into two groups: those with known uveitis (uveitis 
group) and those that presented to the referral centre 
for other disease processes (non-uveitis group).
To meet the inclusion criteria for the uveitis group, 
dogs had to present with at least three of the following 
clinical signs for acute-onset uveitis: corneal oedema, 
keratic precipitates, ocular hyperaemia (conjunctival 
hyperaemia, scleral blood vessel congestion), aqueous 
flare, hypopyon, hyphema, miosis, vitreous cellularity, 
chorioretinitis and hypotony (defined as an intraocular 
pressure <5 mmHg12). Cases with optic neuritis and at 
least two clinical signs of uveitis, mentioned previously, 
were also included in the uveitis group.
The inclusion criteria for the non-uveitis group were 
that at clinical examination there were no indications 
of uveitis as listed above. This included patients who 
presented to the practice due to other ocular diseases 
including eyelid abnormalities, internal medicine or 
orthopaedic conditions.
Both groups (uveitis and non-uveitis groups) consisted 
of dogs from the retrospective (June 2005 to December 
2014) and prospective periods (January 2015 to 
December 2015).
Dogs included in the retrospective part of the study 
had undergone an ophthalmic examination performed 
by the same boarded ophthalmologist (JWC). All dogs in 
the prospective part of the study were examined by the 
same veterinary ophthalmology resident (GK) and super-
vised by the same boarded ophthalmologist (JWC) as in 
the retrospective part of the study.
serum samples
Throughout the entire study period, blood samples 
were collected by jugular venipuncture and handled in 
accordance with the good laboratory practice guidance 
and practice standard operating procedure. The samples 
were left to clot at room temperature between six and 
seven hours. Serum was then separated from the clot by 
centrifugation at 1800 g for 10 minutes and if not imme-
diately dispatched to the laboratory, stored at −20°C until 
dispatched.
serological assay
Serological detection of total immunoglobulin and 
IgG to T gondii was performed at an external veterinary 
laboratory using a commercial LAT and carried out 
according to the manufacturer’s instructions. The test 
was performed in microtitre plates with V-shaped wells. 
Each serum sample was diluted 1:16 with the diluent 
buffer, and 25 microlitres of the diluted test sample was 
further diluted with an equal volume of buffer solution, 
generating serial twofold dilutions from 1:16 to 1:1024. 
Latex reagent (0.1 per cent Toxoplasma antigen-sensi-
tised polystyrene latex suspension) was added to the 
sample wells and compared with the positive control 
(anti-toxoplasma-containing swine serum). The plates 
were analysed in daylight against a dark background. A 
positive result was determined when agglutination was 
detected and compared with a positive control. The 
cut-off titre was taken as 1:64 according to the manufac-
turer's instructions, and an endpoint titre was established 
for positive samples. A negative reaction was indicated by 
sunken latex on the bottom of the well. To detect IgG 
only, 2-mercaptoethanol was added to an aliquot of test 
serum to remove all antibodies of the IgM class.
The results for total immunoglobulin titre and an 
IgG class titre were assessed and compared for both the 
uveitis and non-uveitis groups. Although the presence 
of IgM may be inferred if total immunoglobulin titre 
is greater than the IgG titre, the addition of 2-mercap-
toethanol removes all antibodies of the IgM class and not 
just those specific to Toxoplasma. This means that it is not 
possible to calculate a specific T gondii IgM titre. Fisher's 
exact test was used to test for differences in the seroprev-
alence rates of dogs in the uveitis and non-uveitis groups. 
For statistical analyses, P<0.05 was considered to indicate 
significance.13
Results
study population
In total, 135 dogs met the inclusion criteria for the study. 
The dogs were assigned to an uveitis group consisting of 
51 dogs or a non-uveitis group consisting of 84 dogs.
Open access
3Kosec G, et al. Vet Rec Open 2019;0:e000318. doi:10.1136/vetreco-2018-000318
The male/female ratio was 1:2.2 in the uveitis group 
compared with 1:0.9 in the non-uveitis group. Age 
presentation between male and female dogs was similar 
in the uveitis group; however, the average age of male 
dogs was greater than that of females in the non-uveitis 
group. Testing for differences in seroprevalence between 
male and female dogs with and without uveitis, including 
age as a covariate, was not possible with the small sample 
population, and had not been an aim of the study. 
Comparison of age and sex distribution for the uveitis 
and non-uveitis groups is summarised in table 1.
The most common breeds in the uveitis group were 
labrador retriever (18 per cent) and golden retriever 
(12 per cent), followed by border collie, springer 
spaniel and crossbreed (8 per cent). The most common 
breeds in the non-uveitis group were Jack Russell terrier 
(17 per cent), labrador retriever (10 per cent) and border 
collie (8 per cent).
serology
The overall seroprevalence of anti-T gondii antibodies in 
this study was found to be 6.7 per cent (n=9).
The results of serological testing as per LAT revealed 
dogs positive for anti-T gondii antibodies (≥1:64 total 
immunoglobulin). The seroprevalence results of the LAT 
for the uveitis and non-uveitis groups are summarised in 
table 2.
Overall, there were nine dogs with a total immunoglob-
ulin titre of greater than or equal to the 1:64 cut-off: four 
in the uveitis group and five in the non-uveitis group. 
Of the nine dogs, with a total immunoglobulin titre of 
greater than or equal to the 1:64 cut-off, six were positive 
for an IgG titre greater or equal to our cut-off of 1:64 (one 
in the uveitis group and four in the non-uveitis group).
Of the same group of nine dogs, there were four dogs 
present with identical total immunoglobulin and IgG 
titres (one in the uveitis group and three in the non-uve-
itis group). Therefore, by inference there was no detect-
able level of other immunoglobulins direct to T gondii 
in these dogs with IgM being the major component. 
This does not preclude these patients from having active 
clinical infection with T gondii but may suggest that they 
are not acute cases or may have retained a positive sero-
logical titre following previous exposure. On the other 
hand, there were five dogs present (three in the uveitis 
group and one in the non-uveitis group) with higher 
total immunoglobulin titres in comparison to IgG.
In the uveitis group, 7.8 per cent (n=4) of dogs tested 
positive for anti-T gondii antibodies. Comparison of clin-
ical signs in the uveitis group is summarised in table 3.
In the non-uveitis group, 6.0 per cent (n=5) of dogs 
tested positive for anti-T gondii antibodies. Comparison 
of clinical signs in the non-uveitis group is summarised 
in table 4.
The most common clinical signs of uveitis are 
summarised in table 5. These included ocular hyper-
aemia (65.0 per cent; n=33), aqueous flare (61.0 per cent; 
n=31) and corneal oedema (37.0 per cent; n=19). Uveitis T
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was present in the left eye (27.5 per cent; n=14) of dogs, 
in the right eye (21.5 per cent; n=11) and bilaterally 
(51.0 per cent; n=26).
statistics
Table 6 shows the comparison of the seroprevalence rates 
of the uveitis and non-uveitis groups. Fisher's exact test 
of the difference in seroprevalence between the uveitis 
and non-uveitis groups of dogs yielded a P value of 0.729. 
This result is not significant at the 5 per cent level, indi-
cating that there was no significant difference between 
the groups with or without uveitis.
Age distribution is not statistically significant in this 
study population (Fisher's exact test P=0.33).
dIsCussIOn
The main objective of this study was to demonstrate 
whether LAT serology for the detection of anti-T gondii 
antibodies was beneficial in dogs suspected of ocular 
toxoplasmosis. In the population studied there was no 
significant difference at the 5 per cent level in the sero-
prevalence of T gondii for uveitis and non-uveitis dogs as 
per LAT serology. There are two key points one should 
take into consideration when interpreting anti-T gondii 
antibody test results in dogs. First, no single serological 
test exists that can definitively confirm toxoplasmosis. 
Secondly, comparison of serology results between the 
different tests is difficult due to the variation in serolog-
ical techniques and the choice of threshold for positive 
cut-off values. However, combining tests significantly 
improves the diagnostic sensitivity.14 15 In this study, the 
LAT was selected as the method of choice due to the 
availability and established protocol for dogs by the labo-
ratory. Furthermore, the laboratory regularly assesses 
the appropriateness of this kit for determining antibody 
titres in dogs through participation in an external quality 
assurance scheme run by the Veterinary Laboratory 
Association through their Quality Assurance Program in 
the USA.
Different tests are available when testing for the pres-
ence of T gondii. Indirect haemagglutination tests, fluo-
rescent antibody tests, LATs, modified agglutination tests, 
ELISA,16 Sabin-Feldman dye tests10 17–19 and others have 
been described in different publications.20 The dye test, 
first developed by Sabin and Feldman in 1948, has been 
considered the gold standard for the detection of anti-T 
gondii antibodies in humans.20 The test is technically 
difficult to perform and hazardous because live virulent 
tachyzoites are used.20 The LAT showed adequate perfor-
mance in sensitivity and specificity for the detection 
of anti-T gondii antibodies in humans21 but low perfor-
mance in sheep.22 It has been evaluated for diagnosis of 
toxoplasma infection in pigs, cats, dogs and rodents, and 
a positive titre is defined as greater than or equal to 1:64 
dilution.23 24 Application of the LAT for the diagnosis of 
toxoplasma infection in dogs was not proved successful 
in 1981.24 The agglutination test is based on the aggluti-
nation of organisms in the presence of a specific immu-
noglobulin in the patients’ sera and does not require 
species-specific conjugates.25 Agglutination tests can be 
therefore performed on sera from any species without 
modification.25
The LAT test reports total immunoglobulin as it does 
not differentiate between the different immunoglobulin 
classes.26 In theory, the majority of the immunoglobulin 
in serum consists of IgG and IgM.26 By adding 2-mercap-
toethanol at a defined concentration to the sample, it is 
possible to denature all antibodies of the IgM class and 
report IgG only.26 IgG is more resistant to degradation by 
2-mercaptoethanol than other immunoglobulin classes.26
The LAT results (table 2) show the highest positive titre 
for total immunoglobulin and for IgG after the sample 
was treated with 2-mercaptoethanol. The study reports 
Table 2 Seroprevalence as measured by a LAT for Toxoplasma gondii in the uveitis and non-uveitis groups
Positive total immunoglobulin at dilution 1:64 1:256 1:128 1:256 1:1024 1:1024
Positive IgG at dilution 1:32 1:64 1:128 1:256 1:512 1:1024
Number of dogs positive for the LAT in uveitis group 2 1 0 1 0 0
Number of dogs positive for the LAT in non-uveitis group 1 0 1 1 1 1
LAT, latex agglutination test.
Table 3 Comparison of clinical signs in the uveitis group
Clinical signs n
Unilateral uveitis 1
Bilateral hyphema bilateral hyphaemia and anterior uveitis due 
to immune-mediated thrombocytopenia
1
Unilateral episcleritis and anterior uveitis 1
Unilateral posterior uveitis with associated vitreous 
haemorrhage
1
n, number of animals.
Table 4 Comparison of clinical signs in the non-uveitis 
group
Clinical signs n
Bilateral episcleritis 1
Optic neuritis 1
Lameness 1
Unilateral cataract formation 1
Cardiomyopathy 1
n, number of animals.
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nine (6.7 per cent) positive cases, this comprised four 
(7.8 per cent) in the uveitis and five (6 per cent) in the 
non-uveitis group. Fisher's exact test gives a P value of 
0.73. This supports the view of there being no significant 
difference in the seroprevalence to anti-T gondii antibody 
between the two groups at the 5 per cent level.
Demonstrating rising IgG titres in serum samples 
obtained at three-week intervals in the absence of any 
specific therapy is suggestive in humans of an infection 
acquired less than two months before the first sample, 
but one must be aware that treatment may also reduce 
or abolish the increase in IgG titres.8 The study design 
does not report paired samples, therefore the results are 
reporting seroprevalence to specific antibodies in uveitis 
in random non-uveitis dogs only, rather than rising 
titres, which could assign T gondii as a causative agent for 
toxoplasmosis.
IgM antibodies are produced in humans during the 
first week following infection and reach a plateau within 
one month. IgM antibodies usually decrease after one 
to six months; they become negative in 25 per cent of 
human patients within less than seven months but more 
commonly remain detectable for a year or longer.8 
Regardless of the methodology used for detection, IgG 
synthesis reaches a plateau within two or three months, 
decreases more or less rapidly and persists lifelong at 
residual titres, which are highly variable among patients.8 
To the best of the authors’ knowledge there are no 
published studies of anti-T gondii antibody dynamics in 
the dog and currently there is no single serological test 
that can definitively confirm toxoplasmosis.
Due to problems with IgM not being a reliable marker 
of a recent infection in humans, IgG avidity is used. IgG 
avidity demonstrates that antibody binding becomes 
stronger the longer the host has been infected.8 However, 
this phenomenon has not yet been demonstrated in dogs.
The diagnostic LAT test used within this study will 
determine the total immunoglobulin and IgG levels 
within a sample, but does not give a specific titre value for 
IgM. This is because the 2-mercaptoethanol used within 
this test has the ability to remove all antibodies of the IgM 
class from the serum and not just that specific for T gondii, 
hence preventing the summation of the projected IgM 
value with the IgG to give the total immunoglobulin. A 
study by Cabral et al using a LAT test added a second stage 
using 2-mercaptoethanol in samples which had a positive 
titre of equal to or greater than 1:512.27 This study gave 
an indication of IgM presence in these samples but only 
as an inference of the change in titre after the addition of 
2-mercaptoethanol. No actual values were given.
One method to demonstrate active local infection to 
T gondii is by comparing local antibody production with 
serum antibody levels. This has been confirmed in cats 
experimentally infected with T gondii by demonstrating 
the Witmer-Goldmann coefficient, or the so-called ‘C 
value’.28 29 The C value is the ratio of aqueous antibody 
titre to serum titre.28 29 A C value greater than 1 indi-
cates that an intraocular infectious agent is causing iridal 
plasma cells to produce antibodies, thus demonstrating 
that an infectious agent is causing the uveitis rather than 
merely being a bystander.6 To date, there have been no 
publications looking at the Witmer-Goldmann coeffi-
cient using T gondii titres within the dog, and it has only 
been used in a single publication in a group of dogs 
in Brazil that were naturally infected with Leishmania 
chagasi.30
The authors have been unable to locate any published 
study showing the seroprevalence of anti-T gondii anti-
bodies in dogs with uveitis. In a study of cats with uveitis, 
18.3 per cent of them were found to be seropositive for 
anti-T gondii antibodies.31 A study of 102 dogs with uveitis 
performed at North Carolina State University Veterinary 
Teaching Hospital does not report the seroprevalence 
rates of anti-T gondii antibodies despite 57.8 per cent of 
dogs being diagnosed with idiopathic/immune-mediated 
uveitis.32
A comparison of serology results between studies 
using the LAT for detection of anti-T gondii antibodies 
shows higher (6.7 per cent) seroprevalence of anti-T 
gondii antibodies in the study than in one performed in 
Tokyo, 1.8–1.9 per cent11; but lower than in Thailand, 
11 per cent33; Korea, 12.8 per cent34; Taiwan (China), 
19.6 per cent35 and 20.1 per cent36; and Nigeria, 
25 per cent.37
Table 5 The most common clinical signs of uveitis
Clinical signs of uveitis n %
Ocular hyperaemia 33 65
Aqueous flare 31 61
Corneal oedema 19 37
Ocular hypotony (IOP<5) 16 31
Fibrin, hyphaemia or hypopyon 13 25
Miosis 9 18
Retinal detachment, chorioretinitis 11 21
Keratic precipitates 7 14
Optic neuritis with uveitis 8 16
Vitreous cellularity 4 8
IOP, intraocular pressure.
Table 6 Comparison of the seroprevalence rates of anti-
Toxoplasma gondii antibodies between the uveitis and non-
uveitis groups
Results Positive Negative
Sum of both uveitis 
and non-uveitis 
groups
Uveitis group 4 47 51
Non-uveitis group 5 79 84
Marginal column 
totals
9 126 135 (grand total)
Fisher's exact test gives a P value of 0.73, which is not significant 
at the 5% level.
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One reason for the low seroprevalence of anti-T gondii 
antibodies in this study could be associated with the 
living conditions and diet of the dogs. Worming status 
and lifestyle of the dogs were not collected; however, all 
dogs were family owned with a good welfare background. 
Further investigation would benefit from a questionnaire 
involving feeding habits (commercial diet v Biologically 
Appropriate Raw Food diet or home prepared food) and 
worming history including agent used. In humans, eating 
raw or undercooked meat increases the risk of infection 
but was not associated with development of ocular toxo-
plasmosis.38 The infection rate was higher in strays, guard 
dogs, or dogs fed on a raw meat diet than in household 
dogs.34 35 39–42 There was no information gathered about 
the lifestyle of the dog (working or pet dogs) in this study.
There were not sufficient data to test for differences 
in seroprevalence or susceptibility to uveitis across 
breeds. However, the fact that labrador retrievers, golden 
retrievers and border collies were among the most 
common breeds in both groups suggests that the results 
should not be strongly biased by unknown genetic factors.
Low dose of infective agent at the time of the infec-
tion, age of the host at the time of infection and an 
infection with a different infective stage of the organism 
(tachyzoite, oocyst, cyst) may also cause false negative 
results.43 Furthermore, organism strain may have an 
important role in seroconversion; for example, kittens 
from queens infected with ME-49 and Maggie strains of 
T gondii developed chorioretinitis consistent with ocular 
toxoplasmosis but failed to produce detectable anti-T 
gondii antibodies.43 The ability of T gondii to cause ocular 
disease without systemic disease is poorly understood.44 
Immune-mediated uveitis without systemic disease 
may be due to exposure to T gondii antigens at non-oc-
ular locations and homing of activated immune cells to 
ocular tissues, molecular mimicry, circulating antigens 
or immune complexes from non-ocular sites of para-
site replication and a non-specific increase in immune 
response.2 4
The time frame of the retrospective part of this study 
was 10.5 years; however, the time frame of the prospec-
tive part was only one year. There may be a difference 
in seroprevalence rates to anti-T gondii antibodies in the 
past decade that could influence the current results. 
However, a study of shelter dogs in Tokyo showed only a 
mild increase in seroprevalence rates of anti-T gondii anti-
bodies over the past decade.11 To our knowledge, there 
are no reports of seroprevalence rates for anti-T gondii 
antibodies in dogs in the UK. Our overall seroprevalence 
rate for anti-T gondii antibodies may reflect a seropreva-
lence in the south-west region of the UK and may differ 
from the seroprevalence rate in the overall dog popula-
tion in the UK. Furthermore, the relatively small sample 
size in this study limits the power of the statistical tests 
used.
Only the prospective part of the study was closely moni-
tored and standardised; however, for all blood collections 
and handling in the retrospective part of the study, the 
good laboratory practice guidance was followed at all 
times to ensure the generation of high-quality and reli-
able test results.
Despite our results showing no correlation between 
seroprevalence of anti-T gondii antibodies in dogs with 
and without uveitis, T gondii still remains one of the poten-
tial causes for uveitis. The clinical importance of ocular 
toxoplasmosis for canine uveitis needs to be further eval-
uated. Due to the variety of test kits for T gondii antibody 
detection, information for cut-off values for each type of 
test is crucial to properly assign the result.
Despite showing that there was no significant differ-
ence between the groups, the statistical power was fairly 
low and indicated that given the low incidence rates, a 
much larger sample population would be ideal.
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